Table 2.
Distribution of microorganisms grown in urine cultures
| Female patients (n=1227) (%) | Male patients (n=488) (%) | Total (n=1715) (%) | |
|---|---|---|---|
| E. coli | 799 (65.1%) | 240 (49.1%) | 1039 (60.6%) |
| Enterococcus spp. | 121 (9.9%) | 55 (11.2%) | 176 (10.3%) |
| Klebsiella spp. | 84 (6.8%) | 41 (8.3%) | 125 (7.3%) |
| Pseudomonas spp. | 32 (2.6%) | 50 (10.1%) | 82 (4.8%) |
| Streptokoklar | 54 (4.4%) | 2 (0.4%) | 56 (3.3%) |
| Enterobacter spp. | 20 (1.6%) | 25 (5.1%) | 45 (2.6%) |
| Candida spp. | 36 (2.0%) | 8 (1.5%) | 44 (2.6%) |
| Proteus spp. | 24 (2.0%) | 13 (2.6%) | 37 (2.2%) |
| Citrobacter spp. | 16 (1.3%) | 18 (3.6%) | 34 (2.0%) |
| MSCNS* | 17 (1.4%) | 13 (2.6%) | 30 (1.7%) |
| MRCNS** | 9 (0.7%) | 9 (1.7%) | 18 (1.0%) |
| MSSA*** | 4 (0.3%) | 3 (0.6%) | 7 (0.4%) |
| Acinetobacter spp. | 2 (0.2%) | 5 (1.0%) | 7 (0.4%) |
| MRSA**** | 4 (0.3%) | 2 (0.4%) | 6 (0.3%) |
| Morganella spp. | 2 (0.2%) | 2 (0.4%) | 4 (0.2%) |
| S. maltophilia | - | 2 (0.4%) | 2 (0.1%) |
| Haemophilus spp. | 2 (0.2%) | - | 2 (0.1%) |
| Serratia spp. | 1 (0.1%) | - | 1 (0.1%) |
| Total: | 1227 (100%) | 488 (100%) | 1715 (100%) |
*
MSCNS, Meticilline-susceptible coagulase negative staphylococci;
**
MRCNS, Meticilline-resistance coagulase negative staphylococci,
***
MSSA, Meticilline-susceptible S. aureus;
****
MRSA, Meticilline-resistance S. aureus